Structure Therapeutics Obesity Candidate Is 'Very Competitive' To Eli Lilly's Orforglipron, Analyst Says
Eli Lilly & Co. · PHARMACEUTICAL PREPARATIONS · Now $1082.20
+14% in 7d after detection
Post-detection moves
1h
—
1d
+3.4%
3d
+5.4%
7d
+14%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS